Sandoz Group AG (LON: 0SAN)

Market Cap	16.47B
Revenue (ttm)	8.00B
Net Income (ttm)	-6.33M
Shares Out	n/a
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	589
Average Volume	39,312
Open	42.20
Previous Close	41.67
Day's Range	42.04 - 42.20
52-Week Range	23.50 - 42.20
Beta	n/a
RSI	73.88
Earnings Date	Mar 5, 2025

About Sandoz Group AG

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland.

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1886
• Employees: 22,633
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0SAN

Financial Performance

In 2023, Sandoz Group AG's revenue was $9.98 billion, an increase of 7.23% compared to the previous year's $9.31 billion. Earnings were $77.00 million, a decrease of -90.92%.

Financial numbers in USD